11β-Hydroxysteroid Dehydrogenase Types 1 and 2: An Important Pharmacokinetic Determinant for the Activity of Synthetic Mineralo- and Glucocorticoids
The DOI matches its Crossref record; 33 of the 38 references it cites were found in a registry or an index.
Abstract
The 11beta-hydroxysteroid dehydrogenase (11beta-HSD) system plays a pivotal role in glucocorticoid (GC) and mineralocorticoid (MC) action. Although 11beta-HSD activities are important determinants for the efficacy of synthetic MCs and GCs, corresponding pharmacokinetic data are scanty. Therefore, we characterized 11beta-HSD profiles for a wide range of steroids often used in clinical practice. 11beta-HSD1 and 11beta-HSD2 were selectively examined in 1) human liver and kidney cortex microsomes, and 2) Chinese hamster ovarian cells stably transfected with 11beta-HSD1 or 11beta-HSD2 expression vectors. Both systems produced concordant evidence for the following conclusions. Oxidation of steroids by 11beta-HSD2 is diminished if they are fluorinated in position 6alpha or 9alpha (e.g. in dexamethasone) or methylated at 2alpha or 6alpha (in methylprednisolone) or 16alpha or 16beta, by a methylene group at 16 (in prednylidene), methyloxazoline at 16, 17 (in deflazacort), or a 2-chlor configuration. Whereas the methyl groups also decrease reductase activity (steric effects), fluorination increases reductase activity (negative inductive effect), leading to a shift to reductase activity. This may explain the strong MC activity of 9alpha-fluorocortisol and should be considered in GC therapy directed to 11beta-HSD2-expressing tissues (kidney, colon, and placentofetal unit). 11beta-HSD2 oxidation of prednisolone is more effective than that of cortisol, explaining the reduced MC activity of prednisolone compared with cortisol. Reduction by 11beta-HSD1 is diminished by 16alpha-methyl, 16beta-methyl, 2alpha-methyl, and 2-chlor substitution, whereas it is increased by the Delta(1)-dehydro configuration in prednisone, resulting in higher hepatic first pass activation of prednisone compared with cortisone. To characterize a GC or a MC as substrate for the different 11betaHSDs may be essential for an optimized steroid therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is the reason why, when these compounds are injected in a tissue without 11β-HSD1, they have no biological activity.”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [72]
Experimental — accuracy not yet measuredIn the citing paper
“The biological activity of cortisone and prednisone depends on first pass activation by hepatic 11β-hydroxysteroid-dehydrogenase type 1 (11β-HSD1) [72].”
From Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis (2017) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398
Jamieson, P. M., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1995) · Endocrinology · doi:10.1210/en.136.11.4754 · Cited by 301
Krozowski, Z., MaGuire, J. A., Stein-Oakley, A. N., Dowling, J., Smith, R. E., & Andrews, R. K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608280 · Cited by 252
Barf, T., Vallgårda, J., Emond, R., Häggström, C., Kurz, G., Nygren, A., Larwood, V., Mosialou, E., Axelsson, K., Olsson, R., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025530f · Cited by 211
Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1
Ricketts, M. L., Verhaeg, J. M., Bujalska, I., Howie, A. J., Rainey, W. E., & Stewart, P. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4706 · Cited by 197
Localization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues.
Smith, R. E., Maguire, J. A., Stein-Oakley, A. N., Sasano, H., Takahashi, K., Fukushima, K., & Krozowski, Z. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784076 · Cited by 146
Conversion of cortisone to cortisol and prednisone to prednisolone.
Jenkins, J. S., & Sampson, P. A. (1967) · BMJ · doi:10.1136/bmj.2.5546.205 · Cited by 141
BALLARD, P. L., CARTER, J. P., GRAHAM, B. S., & BAXTER, J. D. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-2-290 · Cited by 135
Bujalska, I. J., Shimojo, M., Howie, A., & Stewart, P. M. (1997) · Steroids · doi:10.1016/s0039-128x(96)00163-8 · Cited by 124
Cited by
Items 101–154 of 154
The glucocorticoid receptor in skeletal health and disease: insights from targeted knockout mice
Macfarlane, E., Zhou, H., & Seibel, M. J. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0399 · Cited by 7
Management of Glucocorticoid Replacement in Adult Growth Hormone Deficiency
Nyström, H. F., & Johannsson, G. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097573 · Cited by 8
“but these are only partially helpful. Thus, in the absence of objective variables for monitoring the adequacy of replacement therapy, the physician mainly has to rely on clinical signs and symptoms. Signs and symptoms of undertreatment include malaise, postural hypotension, poor response to stress, electrolyte disturb…”
BackgroundModulation in Wistar Rats of Blood Corticosterone Compartmentation by Sex and a Cafeteria Diet
Romero, M. D. M., Holmgren-Holm, F., Grasa, M., Esteve, M., Remesar, X., Fernández–Löpez, J., & Alemany, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057342 · Cited by 15
Chihaoui, M., Madhi, W., Yazidi, M., Hammami, B., Oueslati, I., Khessairi, N., Grira, W., Bibi, A., Feki, M., & Chaker, F. (2020) · Endocrine · doi:10.1007/s12020-020-02452-9 · Cited by 7
Olivieri, O., Pizzolo, F., Ravagnani, V., Moretti, L., Carletto, A., Faccini, G., Pasini, F., Friso, S., & Corrocher, R. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f2d35e · Cited by 7
Recycling glucocorticoids: therapeutic implications of the 11β-HSD1 enzyme system
Tsai, K. H.-Y., & Cooper, M. S. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0289 · Cited by 6
Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles
Meduri, G. U., Confalonieri, M., Chaudhuri, D., Rochwerg, B. N., & Meibohm, B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817558-3.00019-6 · Cited by 11
Metabolic considerations of drugs in the treatment of allergic diseases
García‐Martín, E., Cantó, G., & Agúndez, J. A. G. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.823400 · Cited by 6
“It is biologically inert and it is converted in the liver to the active metabolite prednisolone [56] by 11-b-hydroxysteroid dehydrogenase activity.”
BackgroundLuisa, R.-P. A., & Alejandro, M. F. M. (2011) · InTech eBooks · doi:10.5772/17632 · Cited by 5
Gene regulation by glucocorticoid in ENaC-mediated Na+transport by middle ear epithelial cells
Kim, B. G., Kim, J. Y., Kim, M., Kim, C., Choi, J. Y., & Kim, S. H. (2013) · The Laryngoscope · doi:10.1002/lary.24397 · Cited by 6
“Dexamethasone, 9a-Fluorinated steroid, was reported to be regenerated by increasing reductase activity of 11b-HSD.(23) This observed decrease in 11b-HSD1 transcripts might be due to the negative feedback resulting from the over-expression of ENaC induced by steroids.”
BackgroundZhang, Y., Piao, H., & Chen, D. (2024) · Metabolites · doi:10.3390/metabo14110641 · Cited by 8
“The significant downregulated gene FABP1 in iPT cells increased with the progression of DKD [46], and HSD11B2 linked to intra-adipose cortisol levels and peripheral glucose uptake [62], may be crucial for optimizing steroid therapy [63].”
Vincenzo, M. D., Pellegrino, P., Schiappa, G., Campanati, A., Vescovo, V. D., Piccirillo, S., Ambrogini, P., Arnaldi, G., & Orciani, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031357 · Cited by 6
Meduri, G. U. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2691-6148 · Cited by 8
Pharmacology of Glucocorticoids
Arafah, B. M. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_3 · Cited by 5
Wu, N., Katz, D. A., & An, G. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01278-8 · Cited by 5
König, L., Brixius‐Anderko, S., Milhim, M., Tavouli‐Abbas, D., Hutter, M. C., Hannemann, F., & Bernhardt, R. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27246 · Cited by 5
Glucocorticoids and Bone Mineral Content in the Childhood Nephrotic Syndrome
Sugiyama, T., Tanaka, H., & Taguchi, T. (2004) · New England Journal of Medicine · doi:10.1056/nejm200412163512519 · Cited by 5
Vilaça-Júnior, P. E. A., Soares, A. F., Teixeira, V. W., Araújo, A. C. C., & Teixeira, Á. A. C. (2012) · Arquivo Brasileiro de Medicina Veterinária e Zootecnia · doi:10.1590/s0102-09352012000300012 · Cited by 4
Meulebroek, L. V., Clercq, N. D., Bussche, J. V., Devreese, M., Fichant, E., Delahaut, P., Croubels, S., & Vanhaecke, L. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1158-5 · Cited by 4
“866 h, respectively), indicating a very fast conversion of prednisolone into prednisone by the 11β-hydroxysteroid dehydrogenase type 2 enzyme in the liver [24].”
BackgroundFurman, B. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.97806-1 · Cited by 4
Pudrith, C., Kim, Y. H., Martin, D., Gupta, A. D., Inman, J. C., Wareham, R., Jahng, P., Chung, Y. S., Wall, G. M., & Jung, T. T. K. (2010) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2010.08.003 · Cited by 4
Karaca, Z., Tanrıverdi, F., Atmaca, H. N., Unluhizarci, K., & Keleştimur, F. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.04.008 · Cited by 5
Dattaray, P., Pudrith, C., Nyc, M. A., Martin, D., Kim, Y. H., Jahng, P., Chung, Y. S., Wall, G. M., & Jung, T. T. K. (2011) · Otolaryngology · doi:10.1177/0194599811403868 · Cited by 4
“Dexamethasone is fluorinated, which makes the drug much more potent by increasing the reductase activity compared with nonfluorinated hydrocortisone.(12) Currently, ciprofloxacin 0.”
BackgroundCai, B., Li, L., Ma, P., Tao, L., Wei, J. J., Li, H., Shao, Z., Yao, Y., Zhong, Y., & Li, Y. (2025) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-00865-8 · Cited by 3
Meduri, G. U. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2691-6206 · Cited by 3
Rationale and design of the CORE (COrticosteroids REvised) study: protocol
Stam, S. P., Vulto, A., Vos, M. J., Kerstens, M. N., Rutgers, A., Kema, I. P., Touw, D. J., Bakker, S. J. L., & van Beek, A. P. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061678 · Cited by 3
Patel, A., Chowdhury, A. R., Mevada, S., Jadhav, J., Mehta, T., Mukharya, A., Thaker, B. T., & Ameta, R. (2025) · Separation Science Plus · doi:10.1002/sscp.70084 · Cited by 3
Ohnishi, S., Ichiba, H., Saito, M., Hamazaki, T., Matsumura, H., & Shintaku, H. (2016) · Pediatrics International · doi:10.1111/ped.13009 · Cited by 3
Antenatal betamethasone impairs markers of cardiac development and function in near‐term lambs
Amanollahi, R., Meakin, A. S., Holman, S. L., Clifton, V. L., Thornburg, K. L. R., Wiese, M. D., Gatford, K. L., Lock, M. C., & Morrison, J. L. (2025) · Experimental Physiology · doi:10.1113/ep093025 · Cited by 3
“Betamethasone and dexamethasone are potent synthetic glucocorticoids that remain in their active forms and rapidly cross the placenta into the fetal compartment, as they are poor substrates for the deactivating enzyme 11 β -dehydrogenase type 2 (Diederich et al., 2002; Fee et al., 2023).”
Adrenal insufficiency due to high doses of maternal corticosteroid treatment in a premature baby
Blondel, F., Pierron, C., Scalais, E., & Becker, M. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-246961 · Cited by 2
Furman, B. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.97802-4 · Cited by 2
Aspects of diagnosis and treatment of hypopituitarism in adult life
Nyström, H. F. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
Glucocorticoids in pregnancy: a master-switch for fetal maturation
Tan, Y., Stark, M. J., Clifton, V. L., Wiese, M. D., Morrison, J. L., & Gatford, K. L. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag015 · Cited by 1
Colina, M., & Campana, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1889058 · Cited by 1
“11 b - HSD type 2 inactivates glucocorticoids through conversion to 11-keto metabolites, protecting mineralocorticoid receptors in the kidney (20).”
Alshogran, O. Y. (2014) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 2
Solid-state NMR investigation of effect of fluorination and methylation on prednisolone conformation
Carillo, K. J., Arco, S. D., Wang, C., & Tzou, D. M. (2015) · Steroids · doi:10.1016/j.steroids.2015.10.012 · Cited by 1
Main, A. M., & Feldt‐Rasmussen, U. (2015) · AACE Clinical Case Reports · doi:10.4158/ep14556.cr · Cited by 3
11β-Hydroxysteroid dehydrogenase type 1 and bone
Cooper, M. S. (2016) · Osteologie/Osteology · doi:10.1055/s-0037-1619027 · Cited by 1
Steroid Replacement in Adrenal Insufficiency
Blair, J., Debono, M., & Ross, R. J. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64307-6 · Cited by 1
Successful use of dexamethasone when prednisolone is not tolerated
Heazlewood, V. J., Ratnapala, M., & Cochrane, L. (2009) · Obstetric Medicine · doi:10.1258/om.2009.090026
Effect of systemic glucocorticoid therapy on bone metabolism: an update
Cooper, M. S. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.111
Karachunskiy, A., Rumyantseva, Y. V., Lagoyko, S., Bührer, C., Tallen, G. R. N., Aleinikova, O., Быданов, О. И., Korepanova, N., Байдун, Л. В., Nasedkina, T. V., et al. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh201587741-50
Adrenal Function and Skeletal Regulation
Chiodini, I., Battista, C., Cairoli, E., Eller-Vainicher, C., Morelli, V., Palmieri, S., Salcuni, A. S., & Scillitani, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-75110-8_7
Bodor, N. S., & Buchwald, P. (2012) · Wiley eBooks · doi:10.1002/9781118407738.ch5
The effects of 7β-OH Epiandrosterone on Cytokine production by human immune cells
Almartagi, M. A. A. (2018) · STAX · doi:10.48730/tq8j-c084
Steroid replacement in adrenal insufficiency
Blair, J., Debono, M., & Ross, R. J. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00147-3
Li, X., & Jusko, W. J. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103637
Blaschke, M., Dressel, I., Koepp, R., Armbrecht, G., Sehmisch, S., Tzvetkov, M. V., Streit, F., Reichardt, H. M., Glüer, C., & Siggelkow, H. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf315
THE ROLE OF SCAVENGER RECEPTOR CLASS B TYPE I-REGULATED INDUCIBLE GLUCOCORTICOIDS IN SEPSIS
Ai, J. (2014) · UKnowledge (University of Kentucky)
Ogunyemi, O. M., Gyebi, G. A., Macaulay, O. S., Olabuntu, B. A., Olaiya, C. O., & Sabiu, S. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.108983
Yu, K., & Bancos, I. (2026) · Pituitary · doi:10.1007/s11102-026-01652-2
Delangre, E. (2021) · theses.fr (ABES) · doi:10.70675/622d48edz59dcz427ez85c9z9da5f8129e84
Zeng, X., Liu, Z.-W., Zhou, J., Li, J.-X., Liang, L., Wang, Y., Xie, Q.-X., & Chen, X. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124390 · Cited by 1
Beismann, J. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5071
Metadata
- Authors
- Diederich, S., Eigendorff, E., Burkhardt, P., Quinkler, M., Bumke-Vogt, C., Rochel, M., Seidelmann, D., Esperling, P., Oelkers, W., & Bähr, V.
- Affiliations
- Freie Universität Berlin (DE)
- Department of Endocrinology, Diabetes, and Nutrition, Klinikum Benjamin Franklin, Freie Universität Berlin (S.D., E.E., P.B., M.Q., C.B.-V., M.R., W.O., V.B.), 12200 Berlin, Germany
- Research Laboratories of Schering AG (D.S., P. E.), 12200 Berlin, Germany
- Corresponding author
- Diederich, Sven
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-12-01
- Volume
- 87
- Issue
- 12
- Pages
- 5695-5701
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2026750991
- Cited by
- 154
- References
- 38
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 6 · 2023: 9 · 2022: 8 · 2021: 5 · 2020: 4 · 2019: 12 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 14
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- 11β-hydroxysteroid dehydrogenase, 11β-hydroxysteroid dehydrogenase type 1, 11β-hydroxysteroid dehydrogenase type 2, glucocorticoids, mineralocorticoids, steroid metabolism, pharmacokinetics, steroid structure-activity relationship, prednisolone, dexamethasone, methylprednisolone, deflazacort, hepatic first-pass metabolism, renal cortex, liver microsomes, CHO cells, glucocorticoid therapy
- MeSH terms
- Animals, Glucocorticoids, Cricetinae, Humans, Hydroxysteroid Dehydrogenases, Kidney Cortex, Microsomes, Microsomes, Liver, Mineralocorticoids, Oxidation-Reduction, Substrate Specificity, Transfection, CHO Cells, 11-beta-Hydroxysteroid Dehydrogenase Type 1, 11-beta-Hydroxysteroid Dehydrogenase Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.